Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Postoperative Instillation Of Sclerosant (10% Povidone Iodine): Total intervention -3 days twice a day
Under aseptic conditions, after aspiration 20 ml of 10% povidone iodine will be in
Sponsors
Dayanand medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Female patients aged 18 years and above Undergoing MRM or BCS with axillary clearance for breast cancer Willingness to provide informed written consent and comply with follow-up schedule
Exclusion criteria
Exclusion criteria: Known allergy or hypersensitivity to 10% povidone iodine. Patient having haemorrhagic drain output on pod 1. Pregnant or lactating women. Patients who decline participation or are unable to provide consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postsurgery clinically significant Seroma formation requiring aspiration after drain removal within 12 weeks of surgery confirmed clinically Timepoint: Follow up weekly for 1st month then every fortnightly for 2nd and 3rd month. | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency & pattern of treatment-related complications. Time to drain removal from day of surgery. Timepoint: Follow up weekly for 1st month then every fortnightly for 2nd & 3rd month. | — |
Countries
India
Contacts
Public ContactKalpesh Laxmanlal Jingar
Dayanand medical college and hospital
Outcome results
None listed